肝癌中的新陈代谢和免疫抑制反应
Patrizio Caini1, Vinicio Carloni1
1Department of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy.
肝细胞癌 (HCC) 的代谢重编程通过改变瘤微环境来推动瘤的生长. 这一过程抑制了抗瘤免疫力,特别是涉及瘤相关巨细胞 (TAMs) 和调节性T细胞 (Tregs).
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 代谢过程中的代谢.
背景情况:
- 肝细胞癌 (HCC) 是最常见的初级肝癌.
- 代谢重编程是HCC发展和进展的关键驱动力.
- 癌细胞代谢的改变会影响瘤微环境 (TME) 和免疫细胞功能.
研究的目的:
- 审查瘤相关巨细胞 (TAMs) 和调节性T细胞 (Tregs) 在HCC中的免疫抑制作用.
- 探索TME中的代谢变化如何驱动免疫抑制.
- 突出针对癌症免疫疗法的免疫细胞代谢的潜力.
主要方法:
- 文献综述侧重于HCC免疫学和癌症代谢.
- 分析代谢重编程影响TME内的免疫细胞的机制.
- 综合当前对TAMs和Tregs在HCC相关免疫抑制中的理解.
主要成果:
- 癌细胞的代谢重编程会产生一种免疫抑制的TME.
- 对营养的代谢竞争和副产品的积累会损害抗瘤免疫力.
- 由代谢变化驱动的TAMs和Tregs在HCC中显著促进免疫逃避.
结论:
- 针对免疫细胞中的代谢途径是HCC的有前途的治疗策略.
- 了解新陈代谢和免疫抑制之间的相互作用对于开发有效的免疫疗法至关重要.
- 重新编程TAM和Treg代谢可以恢复肝癌中抗瘤免疫反应.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
相关概念视频
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cell-mediated Immune Responses
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
